Thursday, December 14, 2006
6:30pm - 9:00pm
Georgia Tech Hotel & Conference Center
800 Spring Street, Atlanta, GA 30308
>View Detailed Map

PROGRAM OVERVIEW

This educational initiative is designed to improve CVD outcomes through optimal management of CHD risk factors. Special emphasis will be placed on lipid lowering in African American patients with multiple risk factors, including dyslipidemia, hypertension, and diabetes.

The burden of CVD and CHD risk in African Americans warrants more effective achievement of recommended treatment goals. Also, improved provider communication of treatment goals and their importance to patients is crucial.

As part of the overall theme, the program will include a clinical trials workshop addressing the fundamental principles involved in the design and conduct of a clinical trial. The importance of racial and ethnic diversity of participants in clinical trials will also be discussed.

PROGRAM CO-CHAIRS

Luther T. Clark, MD, FACC Chief, Division of Cardiovascular Medicine Professor of Clinical Medicine SUNY Health Science Center at Brooklyn Brooklyn, NY

Michelle A. Albert, MD, MPH, FACC Assistant Professor of Medicine and Associate Physician Harvard Medical School Cardiovascular Division Brigham and Women’s Hospital Boston MA

©2006 Association of Black Cardiologists, Inc. All rights reserved.